Uplarafenib

Details

Stereochemistry	ACHIRAL
Molecular Formula	C22H21F3N4O4S
Molecular Weight	494.487
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCCS(=O)(=O)NC1=CC(F)=C(F)C(C(=O)C2=CC3=C(C=C2)N=CC(=N3)N4CCOCC4)=C1F

InChI

InChIKey=HAYBWDINAFTFCJ-UHFFFAOYSA-N

InChI=1S/C22H21F3N4O4S/c1-2-9-34(31,32)28-17-11-14(23)20(24)19(21(17)25)22(30)13-3-4-15-16(10-13)27-18(12-26-15)29-5-7-33-8-6-29/h3-4,10-12,28H,2,5-9H2,1H3

HIDE SMILES / InChI

Molecular Formula	C22H21F3N4O4S
Molecular Weight	494.487
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 20:17:31 UTC 2023` Edited by `admin` on `Sat Dec 16 20:17:31 UTC 2023`
Record UNII	TQU3V7CXC3
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Uplarafenib

Official Name

English

1-Propanesulfonamide, N-[2,4,5-trifluoro-3-[[3-(4-morpholinyl)-6-quinoxalinyl]carbonyl]phenyl]-

Systematic Name

English

uplarafenib [INN]

Common Name

English

N-[2,4,5-Trifluoro-3-[[3-(4-morpholinyl)-6-quinoxalinyl]carbonyl]phenyl]-1-propanesulfonamide

Systematic Name

English

Code System Code Type Description

CAS

1425485-87-5

Created by admin on Sat Dec 16 20:17:31 UTC 2023 , Edited by admin on Sat Dec 16 20:17:31 UTC 2023

PRIMARY

INN

12781

Created by admin on Sat Dec 16 20:17:31 UTC 2023 , Edited by admin on Sat Dec 16 20:17:31 UTC 2023

PRIMARY

PUBCHEM

71506198

Created by admin on Sat Dec 16 20:17:31 UTC 2023 , Edited by admin on Sat Dec 16 20:17:31 UTC 2023

PRIMARY

FDA UNII

TQU3V7CXC3

Created by admin on Sat Dec 16 20:17:31 UTC 2023 , Edited by admin on Sat Dec 16 20:17:31 UTC 2023

PRIMARY

Related Record Type Details


					TQU3V7CXC3

Uplarafenib

ACTIVE MOIETY

Comments:

antineoplastic

Amount: